Wei-Chiao Chang

https://orcid.org/0000-0002-8573-5924

Emailwcc@tmu.edu.tw

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Education

2007 DPhil (Physiology and Genomics), University of Oxford
2001 M.S., Department of Pharmacology, National Cheng Kung University
1999 B.S., School of Pharmacy, Taipei Medical University

Experience

2018.05- Professor, Master Program in Applied Molecular Epidemiology, Taipei Medical University
2018.01- Vice Dean, College of Pharmacy, Taipei Medical University
2015.08- Professor, Department of Clinical Pharmacy, Taipei Medical University
2012.08-2015.07 Associate Professor, School of Pharmacy, Taipei Medical University
2015.08- Associate Professor, Ph.D Program for Translational Medicine, Taipei Medical University
2013.08- Associate Professor, Ph.D Program for Clinical Drug Discovery from Botanical Herbs, Taipei Medical University
2013.08-2019.07 Director, Ph.D Program for Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
2013.08- Associate Professor, Ph.D Program for Neural Regenerative Medicine, Taipei Medical University
2012.10-2013.07 Director, Ph.D Program for Clinical Pharmacogenomics and Pharmacoproteomics, Taipei Medical University
2012.08- Ph.D Program for Neural Regenerative Medicine, Taipei Medical University
2016.04-2017.04 Secretary General, The Pharmaceutical Society of Taiwan
2009.02-2012.07 Assistant Professor, Kaohsiung Medical University
2002.09-2003.10 Deputy Administrator, Food and Drug Administration of Taiwan

Research Interests

Genetic characterization of calcium channel related genes to establish personalized therapy
Molecular identification for human genetic variants and drug responses

Awards

2019 Research Dissertation Award - Excellence Award, Taipei Medical University

Fingerprint

Dive into the research topics where Wei-Chiao Chang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

2 Active
25 Finished

進展性胰臟癌新穎增進免疫療法的治療策略與生物指標-對免疫療法併用方案節拍式化療或射頻燒灼療法之胰臟癌患者進行基因標記和免疫基因組庫之鑑定與分析(2/3)
Chang, W.
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
利用藥物基因體發展急性登革熱病毒感染期間免疫反應之臨床診斷：探討T細胞組庫和C-型凝集素基因家族之遺傳變異(1/3)
Chang, W.
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
利用大型基因資料庫及臨床收案，探討台灣族群ITPKC基因變異在氣喘之角色
Chang, W.
7/1/20 → 2/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
2-1-3 精進核心研究服務平台-胃腸道腫瘤精準醫療奈米與免疫指標暨療法開發
Chang, W.
1/1/20 → 12/31/20
Project: A - Government Institution › d - Ministry of Education
進展性胰臟癌新穎增進免疫療法的治療策略與生物指標－對免疫療法併用方案節拍式化療或射頻燒灼療法之胰臟癌患者進行基因標記和免疫基因組庫之鑑定與分析(1/3)相對補助
Chang, W.
8/1/19 → 7/31/20
Project: A - Government Institution › f - Other (Funded by Government)

2737 Citations
26 h-Index
159 Article
2 Chapter
2 Letter
2 Review article
More

Association of UBE3C variants with reduced kidney function in patients with diabetic kidney disease
Chen, Y. C., Wu, M. Y., Yu, Z. L., Chou, W. H., Lai, Y. T., Kao, C. C., Faridah, I. N., Wu, M. S. & Chang, W. C., Nov 6 2020, In: Journal of Personalized Medicine. 10, 4, p. 1-12 12 p., 210.
Research output: Contribution to journal › Article › peer-review

Open Access
CLEC5A: A Promiscuous Pattern Recognition Receptor to Microbes and Beyond
Sung, P. S., Chang, W. C. & Hsieh, S. L., Jan 1 2020, Advances in Experimental Medicine and Biology. Springer India, p. 57-73 17 p. (Advances in Experimental Medicine and Biology; vol. 1204).
Research output: Chapter in Book/Report/Conference proceeding › Chapter
1 Citation (Scopus)
Editorial: Big Data, Pharmacogenomics and Real-World Research in Pharmacology
Wei, J. C. C., Chang, W. C. & Mushiroda, T., Aug 13 2020, In: Frontiers in Pharmacology. 11, 1239.
Research output: Contribution to journal › Editorial › peer-review

Open Access
Evaluation for the genetic association between store-operated calcium influx pathway (Stim1 and orai1) and human hepatocellular carcinoma in patients with chronic hepatitis b infection
Irham, L. M., Chou, W. H., Wang, Y. S., Adikusuma, W., Wong, H. S. C., Perwitasari, D. A., Huang, W. C., Chen, B. K., Yang, H. I. & Chang, W. C., Nov 2020, In: Biology. 9, 11, p. 1-14 14 p., 388.
Research output: Contribution to journal › Article › peer-review

Open Access
Functional correlations between CXCL10/IP10 gene polymorphisms and risk of Kawasaki disease
Hsu, Y. W., Lu, H. F., Chou, W. H., Kuo, H. C. & Chang, W. C., 2020, (Accepted/In press) In: Pediatric Allergy and Immunology. 32, 2, p. 363-370 8 p.
Research output: Contribution to journal › Article › peer-review

MOESM5 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
Wong, H. (Contributor), Lin, Y. (Contributor), Lu, H. (Contributor), Liao, W. (Contributor), Chen, C. (Contributor), Wu, J. (Contributor), Chang, W. (Contributor) & Tsai, F. (Contributor), Unknown Publisher, Jan 1 2019
DOI: 10.6084/m9.figshare.10270451.v1, https://springernature.figshare.com/articles/MOESM5_of_Genomic_interrogation_of_familial_short_stature_contributes_to_the_discovery_of_the_pathophysiological_mechanisms_and_pharmaceutical_drug_repositioning/10270451/1
Dataset
MOESM9 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
Wong, H. (Contributor), Lin, Y. (Contributor), Lu, H. (Contributor), Liao, W. (Contributor), Chen, C. (Contributor), Wu, J. (Contributor), Chang, W. (Contributor) & Tsai, F. (Contributor), Unknown Publisher, Jan 1 2019
DOI: 10.6084/m9.figshare.10270469.v1, https://springernature.figshare.com/articles/MOESM9_of_Genomic_interrogation_of_familial_short_stature_contributes_to_the_discovery_of_the_pathophysiological_mechanisms_and_pharmaceutical_drug_repositioning/10270469/1
Dataset
MOESM1 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
Wong, H. (Contributor), Lin, Y. (Contributor), Lu, H. (Contributor), Liao, W. (Contributor), Chen, C. (Contributor), Wu, J. (Contributor), Chang, W. (Contributor) & Tsai, F. (Contributor), Unknown Publisher, Jan 1 2019
DOI: 10.6084/m9.figshare.10270427.v1, https://springernature.figshare.com/articles/MOESM1_of_Genomic_interrogation_of_familial_short_stature_contributes_to_the_discovery_of_the_pathophysiological_mechanisms_and_pharmaceutical_drug_repositioning/10270427/1
Dataset
MOESM10 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
Wong, H. (Contributor), Lin, Y. (Contributor), Lu, H. (Contributor), Liao, W. (Contributor), Chen, C. (Contributor), Wu, J. (Contributor), Chang, W. (Contributor) & Tsai, F. (Contributor), Unknown Publisher, Jan 1 2019
DOI: 10.6084/m9.figshare.10270412.v1, https://springernature.figshare.com/articles/MOESM10_of_Genomic_interrogation_of_familial_short_stature_contributes_to_the_discovery_of_the_pathophysiological_mechanisms_and_pharmaceutical_drug_repositioning/10270412/1
Dataset
MOESM2 of Genomic interrogation of familial short stature contributes to the discovery of the pathophysiological mechanisms and pharmaceutical drug repositioning
Wong, H. (Contributor), Lin, Y. (Contributor), Lu, H. (Contributor), Liao, W. (Contributor), Chen, C. (Contributor), Wu, J. (Contributor), Chang, W. (Contributor) & Tsai, F. (Contributor), Unknown Publisher, Jan 1 2019
DOI: 10.6084/m9.figshare.10270436.v1, https://springernature.figshare.com/articles/MOESM2_of_Genomic_interrogation_of_familial_short_stature_contributes_to_the_discovery_of_the_pathophysiological_mechanisms_and_pharmaceutical_drug_repositioning/10270436/1
Dataset